Short answer
Core Laboratories Inc. /DE/ (CLB) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $132M (down 1.8% year over year) with net income of $5M.
Q3 2026 key financials · XBRL
- Revenue
- $132M
- −1.8% YoY · +6.0% QoQ
- Net income
- $5M
- −61.8% YoY · −8.6% QoQ
- Operating margin
- 9.1%
- EPS (diluted)
- $0.12
- −60.0% YoY · −7.7% QoQ
Source: XBRL data from the Core Laboratories Inc. /DE/ (CLB) Q3 2026 10-Q on SEC EDGAR. USD.
Core Laboratories Inc. /DE/ Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $132.1M, down 2% YoY from $134.5M
- Net income $5.5M, 4% margin vs 11% YoY; operating margin 9% vs 16%
- Best segment: Production Enhancement revenue $47.8M, up 3%, margin 9%; Reservoir Description revenue $84.3M, down 4%, margin 9% vs 19%
- Cash $21.4M vs $22.7M at December 31, 2025; operating cash flow $16.7M for nine months vs $29.1M
- Capital deployment: $14.4M capital expenditures, $7.7M share repurchases, $1.4M dividends; geopolitical conflicts and sanctions driving near-term volatility
Risk Factors
- No material changes disclosed from the December 31, 2025 Form 10-K risk factors
- Business performance risk: known or unknown risks could materially affect operations, financial position, or results
- Information risk: currently immaterial or unknown risks may impair business operations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Core Laboratories Inc. /DE/ quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.